MedPath

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

Phase 3
Terminated
Conditions
Anemia
Chronic Renal Insufficiency
Interventions
Registration Number
NCT00701714
Lead Sponsor
Sandoz
Brief Summary

This is a randomized, controlled, double-blind, multicenter multinational safety study involving about 300 predialysis patients aged 18 years or above suffering from anemia.

Symptomatic anemia will be corrected by s.c. application of EPO HEXAL or ERYPO® in order to achieve a hemoglobin target range of 10.0 -12.0 g/dL.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
337
Inclusion Criteria
  • Known chronic renal insufficiency of at least 4 weeks duration; CKD stage at least 3 or higher
  • Male and female patients, age: >=18
  • Patients who are naïve to ESA treatment or previously ESA treated after 3 months of ESA-free period (i.v. or s.c.)
  • Patients with symptomatic anemia, defined as Hb level below 11.0 g/dL and not lower than or equal to 7.5 g/dL on at least 2 visits during the screening period
  • Adequate iron status, serum ferritin >= 100 µg/L or transferrin saturation >= 20%
  • Ability to follow study instructions and likely to complete all required visits and compliant with subcutaneous administration
  • Written informed consent of the patient.
Exclusion Criteria
  • Anemia of non-renal causes
  • Therapy with immunosuppressants (other than corticosteroids for chronic treatment) within 3 months before screening and during the study for patients with renal allograft in place or other chronic conditions (e.g. lupus erythematosus, rheumatic arthritis)
  • Patients previously treated with chronic dialysis within the last 6 months (exception: one session of acute dialysis)
  • Patients with acute deterioration of renal function during the screening phase according to the investigator's judgment
  • Patients receiving any RBC/whole blood transfusion during the screening period
  • Primary hematological disorder (e.g. myeloma, myelodysplastic syndrome, sickle cell anemia, hematological malignancy, hemolytic anemia)
  • Evidence of uncontrolled diabetes mellitus (HbA1c > 10 % at visit -2)
  • Evidence of severe hepatic dysfunction (e.g. ALT and/or AST above 2x upper limit of normal range; or gamma-GT above 3x upper limit of normal range)
  • Clinical evidence of current uncontrolled or symptomatic hyperparathyroidism, defined as parathyroid hormone > 500 ng/L at visit -2.
  • Uncontrolled hypertension, defined as a systolic blood pressure of >= 160 mmHg and a diastolic blood pressure measurement >= 100 mmHg (average of two values with at least one day between measurements)
  • Congestive heart failure and/or angina pectoris [New York Heart Association (NYHA) class III and IV]
  • History of stroke or myocardial infarction during the last 6 months prior to visit -2
  • Ongoing treatment with phenprocoumon or other cumarin derivates
  • Thrombocytopenia (platelet count <100.000/µL) or leucopenia (white blood cell count < 2.000/µL)
  • Gastrointestinal bleeding within the last 6 months prior to visit -2 or hemolysis
  • Evidence of acute or chronic infection by a C-reactive protein value of > 30 mg/L
  • Suspicion or known PRCA (pure red cell aplasia)
  • Previously diagnosed HIV or acute hepatitis infection
  • History of epilepsy or epileptic seizures or treatment for epilepsy within the past 6 months prior to screening
  • Planned major surgery (with expected high blood loss) during the next 3 months or major surgery within the previous 3 months (except laser photocoagulation, access surgery)
  • Clinical evidence of active malignant diseases within the last 5 years (except non-melanoma skin cancer)
  • Pregnancy, breastfeeding women or women not using a highly effective birth control method (e.g. implants, injectables, combined oral contraceptives, IUD, sexual abstinence, vasectomised partner)
  • Known history of severe drug related allergies (e.g. anaphylactic shock)
  • Known allergy to one of the ingredients of the test product or hypersensitivity to mammalian-derived products
  • Known or suspicion of any non-compliance with respect to subcutaneous treatment
  • Simultaneous participation in another clinical study or participation in a study in the month preceding visit-2 or previously randomized in this study
  • Participation in another ESA study in the 3 months preceding visit -2
  • Any other condition which at the investigator's discretion may put the patient at risk or which may confound the study results.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1HX575 recombinant human erythropoietin alfaHX575, EPO HEXAL
2ERYPOERYPO
Primary Outcome Measures
NameTimeMethod
Change in Hemoglobin Level13 weeks

Mean absolute change in hemoglobin (baseline to end of study week 13)

Weekly Epoetin Doseweeks 11-13

Mean weekly epoetin dose \[IU/kg\] in study weeks 11-13

Secondary Outcome Measures
NameTimeMethod
Immunogenicity13 weeks

Number of participants with antibody formation against Epoetin during treatment period (safety set)

Trial Locations

Locations (116)

Diakonissen KH Salzburg

🇦🇹

Salzburg, Austria

LKH Steyr

🇦🇹

Steyr, Austria

Krankenanstalt der Stadt Wien

🇦🇹

Wien, Austria

Kamineni Hospitals Ltd.

🇮🇳

Hyderabaad, India

MHAT Pazardijk

🇧🇬

Pazardzhik, Bulgaria

MHAT Stara Zagora

🇧🇬

Stara Zagora, Bulgaria

Spitalul Clinic Judetean Cluj

🇷🇴

Cluj, Romania

County Hospital Tg Mures

🇷🇴

Tg Mures, Romania

MHAT Sveti Ivan Rilski

🇧🇬

Sofia, Bulgaria

Bombay Hospital

🇮🇳

Indore, India

State Healthcare Institution "Kemerova Regional Clinical Hospital"

🇷🇺

Kemerovo, Russian Federation

Russian University of Peoples Frienship (clinical base: City clinical hospital #53)

🇷🇺

Moscow, Russian Federation

Monilek Hospital and Research Center

🇮🇳

Jaipur, India

NZOZ NEFROLUX Sp. J. Lucjan Sobieraj, Wojciech Kaminski

🇵🇱

Siemianowice Slaskie, Poland

Spitalul Universitar Bucuresti

🇷🇴

Bucuresti, Romania

County Hospital Deva

🇷🇴

Deva, Romania

SC Medicali's SRL

🇷🇴

Timisoara, Romania

Szpital Wojewódzki w Poznaniu

🇵🇱

Poznan, Poland

Specjalistyczne Centrum Diagnostyczno-Lecznicze Bamberski Dwor (Solumed SC)

🇵🇱

Poznan, Poland

Wojewodzki Szpital Specjalistyczny nr. 1 im. Jozefa Gasinskiego

🇵🇱

Tychy, Poland

Centrul Medical de Diagnostic si Tratament Ambulator si Medicina Preventiva Bucuresti

🇷🇴

Bucuresti, Romania

Szpital Praski p.w. Przemienienia Panskiego II Oddzia Chorob Wewnetrznych

🇵🇱

Warszawa, Poland

NZOZ Centrum Badan Klinicznych

🇵🇱

Wroclaw, Poland

Institutul National de DiabetNutritie si Boli Metabolice Paulescu

🇷🇴

Bucuresti, Romania

Institutul Clinic Fundeni

🇷🇴

Bucuresti, Romania

Spitalul Judetean Timisoara

🇷🇴

Timisoara, Romania

Policlinica Dr. Citu

🇷🇴

Timisoara, Romania

State Healthcare Institution "Reoublic Hospital named after VA Baranov"

🇷🇺

Petrozavodsk, Russian Federation

Municipal Institution "City Clinical Hospital #40"

🇷🇺

Ekaterinburg, Russian Federation

Nemocnice Kladno

🇨🇿

Kladno, Czechia

Gesundheitszentrum Alzey

🇩🇪

Alzey, Germany

Nephrologisches Zentrum an Stadtkrankenhaus

🇩🇪

Bad Wildungen, Germany

Praxis Dr. Scharla

🇩🇪

Bad Reichenhall, Germany

Nemocnice s poliklinikou v Novem Jicine

🇨🇿

Novi Jicin, Czechia

Dialysepraxis drs. Riedasch/Schreiber

🇩🇪

Coesfeld, Germany

Gemeinschaftspraxis Karlstraße

🇩🇪

Düsseldorf, Germany

FN Motol

🇨🇿

Praha 5, Czechia

Gemeinschaftspraxis Dr. med. Gert-Peter Dragoun, Dr. med Günther Hevendehl

🇩🇪

Aschaffenburg, Germany

Dialyseplaxis DR. Rieck, DR. Göbel, DR. Wagner

🇩🇪

Krefeld, Germany

KfH Kuratorium für dialyse und Nierentransplantation e.V.

🇩🇪

Nördlingen, Germany

Nephrologische Gemeinschaftspraxis Dr. Rensinghoff & Dr. Becker

🇩🇪

Bochum-Wattenscheid, Germany

Dialcorp, s.r.o.

🇨🇿

Praha 4 - Michle, Czechia

Nefrologická a interní amb.

🇨🇿

Žïár n. Sázavou, Czechia

Studienzentrum Hämatologie / Onkologie / Diabetes

🇩🇪

Aschaffenburg, Germany

Gemeinschaftspraxis und Dialyse

🇩🇪

Hürth, Germany

Dialyse-Centrum

🇩🇪

Bad Windsheim, Germany

KfH Kuratorium f. Dialyse und Nierentransplantation e.V.

🇩🇪

Eberswalde, Germany

Gemeinschaftspraxis Dr. Steffen & Dr. Perino

🇩🇪

Dinkelsbühl, Germany

Praxis Dr. Schütterle

🇩🇪

Marburg, Germany

Praxis Dr. Rose, Pohlmeier und Dr. Lammers

🇩🇪

Münster, Germany

Dialyse Nettetal

🇩🇪

Nettetal, Germany

Nephrologische Praxis Bad Münder

🇩🇪

Bad Münder, Germany

Nemocnice Šternberk

🇨🇿

Šternberk, Czechia

KfH Kuratorium für Dialyse und Nierentransplantation e.V.

🇩🇪

Straubing, Germany

CHU d'Amiens - Hopital Sud

🇫🇷

Amiens, France

GDG Gemeinnützige Dialyse Gesellschaft

🇩🇪

Leverkusen, Germany

MHAT "Sv. Anna"

🇧🇬

Varna, Bulgaria

Litomyslska nemocnice, a.s.

🇨🇿

Litomyšl, Czechia

Schwerpunktpraxis für Diabetologie und Nephrologie

🇩🇪

Bernkastel-Kues, Germany

Praxis Dr. Kraatz

🇩🇪

Demmin, Germany

Nemocnice Prostìjov

🇨🇿

Prostìjov, Czechia

Diabetes- und Dialysezentrum Merker, Vogt

🇩🇪

Dormagen, Germany

Dialysepraxis

🇩🇪

Friedrichroda, Germany

Gemeinschaftspraxis Dres. Leistikow, Hafezi und Sandner

🇩🇪

Mannheim, Germany

IKEM

🇨🇿

Praha 4, Czechia

Specjalistyczna Przychodnia Lekarska Medikard

🇵🇱

Plock, Poland

Emergency Clinical County Hospital

🇷🇴

Timisoara, Romania

NIZAM Institute of Medical Sciences

🇮🇳

Hyderabaad, India

Dialysepraxis Häger, Schanze, Brause

🇩🇪

Düsseldorf, Germany

Praxis Dr. med. Mauersberger

🇩🇪

Villingen-Schwenningen, Germany

Dialysezentrum

🇩🇪

Homberg/Efze, Germany

Praxis Dr. Zimmermann

🇩🇪

Essen, Germany

Med Center Leipzig

🇩🇪

Leipzig, Germany

Praxis Dr. Vogel-Wagner

🇩🇪

Mittweida, Germany

Vinaya Hospital & Research Centre

🇮🇳

Mangalore, India

Klinik für Nephrologie und Allgemeine Innere Medizin

🇩🇪

Solingen, Germany

Pulse Diagnostix Cardiac and Medical Center

🇮🇳

Pune, India

SP ZOZ Miejski Szpital Zespolony

🇵🇱

Czestochowa, Poland

State Health Care Institution City Clinical Hospital named after SP Botkin

🇷🇺

Moscow, Russian Federation

Municipal medical Institution "City Hospital #1"

🇷🇺

Barnaul, Russian Federation

State Educational Institution of Higher Professional Education "Moscow State University of Medicine and dentistry of Federal Agency of health Care and Social Development", City Clinical Hospital #23

🇷🇺

Moscow, Russian Federation

Municipal Healthcare Institution "City Clinical Hospital #2"

🇷🇺

Yaroslavl, Russian Federation

State Educational Institution of Higher Professional Education "Smolensk State Medical Academy of Federal Agency of Health Care and Social Development"

🇷🇺

Smolensk, Russian Federation

Praxis Dr. Lüdemann

🇩🇪

Falkensee, Germany

Leipziger Institut für Präventivmedizin

🇩🇪

Leipzig, Germany

Dialysepraxis Barmbek

🇩🇪

Hamburg, Germany

State Educational Institution of Higher Professional Education "St. Petersburg State Medical Academy named after I.I. Mechnikov of Roszdrav"

🇷🇺

St. Petersburg, Russian Federation

State Institute St. Petersburg

🇷🇺

St. Petersburg, Russian Federation

SibMedCenter LLC

🇷🇺

Tomsk, Russian Federation

State Educational Institution of Higher Professional Education "St. Petersburg State Medical Institute named after IP Pavlov of Roszdrav"

🇷🇺

St. Petersburg, Russian Federation

State Healthcare Institution of Yaroslavl region "Regional Clinical Hosptal"

🇷🇺

Yaroslavl, Russian Federation

AKH Wien

🇦🇹

Wien, Austria

Sozialmedizinisches Zentrum Ost Donauspital

🇦🇹

Wien, Austria

Ambulance vnitrního lékarstvi

🇨🇿

Brno, Czechia

CHU de Rouen - Hopital de Bois Guillaume

🇫🇷

Bois-Guillaume, France

Gemeinschaftspraxis Dr. Spitthöver, Dr. Knee, Dr. Gröschel

🇩🇪

Essen, Germany

Praxis Dipl. med. Kosch

🇩🇪

Pirna, Germany

Dialysepraxis Dipl. med. Gierak & Dipl. med. Rettig

🇩🇪

Quedlinburg, Germany

Gemeinschaftspraxis Dr. Kirchner und Dr. Menge

🇩🇪

Sömmerda, Germany

Kerala Institute of Medical Sciences

🇮🇳

Trivandrum, India

Spitalul Clinic CI Parhon Iasi

🇷🇴

Iasi, Romania

Dr. Gavril Curteanu Clinical Hospital

🇷🇴

Oradea, Romania

State Healthcare Institution "Sverdlovsk Regional Clinical Hospital #1"

🇷🇺

Ekaterinburg, Russian Federation

Federal State Institution "National Medical Surgery center named after NI Pirogov of Federal Agency of Health Care and Social Development"

🇷🇺

Moscow, Russian Federation

State healthcare Institution "Nizhegorodsky Regional Clinical Hospital named after NA Semashko"

🇷🇺

Nizhniy Novgorod, Russian Federation

Municipal healthcare Institution "City Clinical Hospital #2"

🇷🇺

Pyatigorsk, Russian Federation

State Educational Institution of High Professional Education Saratov State Medical University of Roszdrav

🇷🇺

Saratov, Russian Federation

State Healthcare Institution "Ryazan Regional Cardiological Dispensary"

🇷🇺

Ryazan, Russian Federation

State Educational Institution of Higher Professional Education "St. Petersburg State Medical Academy for Postgraduate studies of Roszdrav"

🇷🇺

St. Petersburg, Russian Federation

St. Petersburg State Healthcare Institution "City Mariinsky Hospital"

🇷🇺

St. Petersburg, Russian Federation

State Institution "St. petersburg Clinical research Institute of Emergency Medical Care named after I.I. Dzhanelidze"

🇷🇺

St. petersburg, Russian Federation

St. Petersburg State Healthcare Institution "City Outpatient Clinic #17"

🇷🇺

St. petersburg, Russian Federation

State Institution Scientific Research Institute of Cardiology of Tomsk Research Center of Siberian Branch of Russian Academy of Medical Sciences

🇷🇺

Tomsk, Russian Federation

SMOLKO s.r.o.

🇸🇰

Kosice, Slovakia

MEDIKOL s.r.o.

🇸🇰

Košice, Slovakia

FN Trnava

🇸🇰

Trnava, Slovakia

© Copyright 2025. All Rights Reserved by MedPath